René Kerstens

4.1k total citations · 1 hit paper
65 papers, 2.7k citations indexed

About

René Kerstens is a scholar working on Gastroenterology, Surgery and Epidemiology. According to data from OpenAlex, René Kerstens has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Gastroenterology, 24 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in René Kerstens's work include Gastrointestinal motility and disorders (45 papers), Gastroesophageal reflux and treatments (25 papers) and Congenital gastrointestinal and neural anomalies (13 papers). René Kerstens is often cited by papers focused on Gastrointestinal motility and disorders (45 papers), Gastroesophageal reflux and treatments (25 papers) and Congenital gastrointestinal and neural anomalies (13 papers). René Kerstens collaborates with scholars based in Belgium, United Kingdom and United States. René Kerstens's co-authors include Lieve Vandeplassche, Michael Camilleri, Jan Tack, Eamonn M.M. Quigley, Jannie Ausma, G Beyens, M. Van Outryve, Martine De Pauw, Marita Stevens and Cornelius E. J. Sloots and has published in prestigious journals such as New England Journal of Medicine, Blood and Gastroenterology.

In The Last Decade

René Kerstens

61 papers receiving 2.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

2008 403 citations Michael Camilleri, René Kerstens et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
René Kerstens Belgium	25	2.1k	1.6k	322	293	249	65	2.7k
Salam Zakko United States	16	1.2k 0.6×	875 0.5×	383 1.2×	327 1.1×	154 0.6×	48	2.1k
María Inés Pinto-Sánchez Canada	32	1.9k 0.9×	1.2k 0.7×	310 1.0×	881 3.0×	62 0.2×	83	2.6k
Ahmed Madisch Germany	26	1.1k 0.5×	1.2k 0.7×	134 0.4×	933 3.2×	77 0.3×	113	2.5k
Ho Soon Choi South Korea	25	719 0.3×	965 0.6×	233 0.7×	333 1.1×	66 0.3×	125	2.0k
Byung Chul Yoon South Korea	23	723 0.4×	810 0.5×	233 0.7×	306 1.0×	62 0.2×	75	1.7k
Riadh Sadik Sweden	21	812 0.4×	833 0.5×	340 1.1×	322 1.1×	42 0.2×	49	1.7k
K R Palmer United Kingdom	29	1.2k 0.6×	1.8k 1.1×	142 0.4×	442 1.5×	102 0.4×	52	2.7k
Giles Major United Kingdom	19	648 0.3×	392 0.2×	333 1.0×	216 0.7×	90 0.4×	49	1.4k
Kyung Sik Park South Korea	27	849 0.4×	1.2k 0.7×	193 0.6×	428 1.5×	89 0.4×	149	2.6k
Manuel Díaz‐Rubio Spain	33	639 0.3×	695 0.4×	146 0.5×	496 1.7×	83 0.3×	85	2.2k

Countries citing papers authored by René Kerstens

Since Specialization

Citations

This map shows the geographic impact of René Kerstens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Kerstens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Kerstens more than expected).

Fields of papers citing papers by René Kerstens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Kerstens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Kerstens. The network helps show where René Kerstens may publish in the future.

Co-authorship network of co-authors of René Kerstens

This figure shows the co-authorship network connecting the top 25 collaborators of René Kerstens. A scholar is included among the top collaborators of René Kerstens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Kerstens. René Kerstens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aerts, Joachim G.J.V., Robert A. Belderbos, Paul Baas, et al.. (2024). Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study. The Lancet Oncology. 25(7). 865–878. 5 indexed citations

Djamin, Remco S., Eefje J. A. Schrauwen, Christian J. H. von Wintersdorff, et al.. (2020). Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin. Antimicrobial Resistance and Infection Control. 9(1). 116–116. 9 indexed citations

Djamin, Remco S., Mona Bafadhel, Richard Russell, et al.. (2019). Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations. Respiratory Medicine. 154. 27–33. 2 indexed citations

Camilleri, Michael, Hubert Piessevaux, Yan Yiannakou, et al.. (2016). Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Digestive Diseases and Sciences. 61(8). 2357–2372. 63 indexed citations

Bouchoucha, Michel, Ingolf Schiefke, Hubert Piessevaux, et al.. (2015). PWE-252 Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomised, double-blind, placebo-controlled trial. A323.2–A324. 1 indexed citations

Emmanuel, Anton, et al.. (2014). Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis. The American Journal of Gastroenterology. 109(6). 887–894. 55 indexed citations

Quigley, Eamonn M.M., Jan Tack, Lieve Vandeplassche, & René Kerstens. (2012). Tu1394 The Efficacy and Safety of Oral Prucalopride in Female Patients With Chronic Constipation Who Had Failed Laxative Therapy (EMA-Authorised Population) is Similar to That of the Complete ITT Population in the Initial Pivotal Trials: Pooled Data Analysis. Gastroenterology. 142(5). S–820. 3 indexed citations

Stanghellini, Vincenzo, Lieve Vandeplassche, & René Kerstens. (2011). Best response distribution of 12-week treatment with prucalopride (RESOLOR) in patients with chronic constipation: combined results of three randomised, double-blind, placebo-controlled phase iii trials: Table 1. Gut. 60(Suppl 1). A159.2–A160. 2 indexed citations

Tack, Jan, René Kerstens, & Lieve Vandeplassche. (2011). Efficacy and Safety of Oral Prucalopride in Female Patients With Chronic Constipation: Pooled Data of 3 Pivotal Trials. Gastroenterology. 140(5). S–614. 3 indexed citations

10.

Emmanuel, Anton, Michael A. Kamm, Amanda Roy, René Kerstens, & Lieve Vandeplassche. (2011). Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo‐obstruction – a double‐blind, placebo‐controlled, cross‐over, multiple n = 1 study. Alimentary Pharmacology & Therapeutics. 35(1). 48–55. 73 indexed citations

11.

Camilleri, Michael, et al.. (2010). Clinical trial: the efficacy of open‐label prucalopride treatment in patients with chronic constipation – follow‐up of patients from the pivotal studies. Alimentary Pharmacology & Therapeutics. 32(9). 1113–1123. 65 indexed citations

12.

Sloots, Cornelius E. J., et al.. (2010). Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation. Digestive Diseases and Sciences. 55(10). 2912–2921. 108 indexed citations

13.

Camilleri, Michael, G Beyens, René Kerstens, Peter Robinson, & Lieve Vandeplassche. (2009). Safety assessment of prucalopride in elderly patients with constipation: a double‐blind, placebo‐controlled study. Neurogastroenterology & Motility. 21(12). 1256–1256. 96 indexed citations

14.

Nevens, Frederik, et al.. (2009). 182 EFFECT OF M0002, A NOVEL V2 ANTAGONIST ON SODIUM LEVELS AND WEIGHT GAIN AFFECTED BY WATER ACCUMULATION IN CIRRHOTIC PATIENTS WITH ASCITES. Journal of Hepatology. 50. S76–S76. 4 indexed citations

15.

Moulin, Dwight E., et al.. (2008). 642 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety of Prucalopride (Resolor®) in Patients with Opioid-Induced Constipation. Gastroenterology. 134(4). A–92. 7 indexed citations

16.

Quigley, Eamonn M.M., Lieve Vandeplassche, René Kerstens, & Jannie Ausma. (2008). Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation – a 12‐week, randomized, double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics. 29(3). 315–328. 255 indexed citations

17.

Coremans, Georges, René Kerstens, Martine De Pauw, & Marita Stevens. (2003). Prucalopride Is Effective in Patients with Severe Chronic Constipation in Whom Laxatives Fail to Provide Adequate Relief. Digestion. 67(1-2). 82–89. 93 indexed citations

18.

Sloots, Cornelius E. J., Alexander C. Poen, René Kerstens, et al.. (2002). Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Alimentary Pharmacology & Therapeutics. 16(4). 759–767. 73 indexed citations

19.

Beyer, W.E.P., A.M. Palache, René Kerstens, & N. Masurel. (1996). Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. European Journal of Clinical Microbiology & Infectious Diseases. 15(1). 65–70. 72 indexed citations

20.

Palache, A.M., et al.. (1996). Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents. Vaccine. 14(14). 1327–1330. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact